53 related articles for article (PubMed ID: 31145313)
1. Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.
Xiaoling G; Ying L; Jing L; Huifang L; Xia Z; Qingqing F; Ping Z
Cancer Immunol Immunother; 2005 Nov; 54(11):1106-14. PubMed ID: 15889252
[TBL] [Abstract][Full Text] [Related]
2. Estimating Copy Number and Allelic Variation at the Immunoglobulin Heavy Chain Locus Using Short Reads.
Luo S; Yu JA; Song YS
PLoS Comput Biol; 2016 Sep; 12(9):e1005117. PubMed ID: 27632220
[TBL] [Abstract][Full Text] [Related]
3. ImmunoTyper-SR: A computational approach for genotyping immunoglobulin heavy chain variable genes using short-read data.
Ford MKB; Hari A; Rodriguez O; Xu J; Lack J; Oguz C; Zhang Y; Weber S; Magliocco M; Barnett J; Xirasagar S; Samuel S; Imberti L; Bonfanti P; Biondi A; Dalgard CL; Chanock S; Rosen L; Holland S; Su H; Notarangelo L; ; Vishkin U; Watson CT; Sahinalp SC
Cell Syst; 2022 Oct; 13(10):808-816.e5. PubMed ID: 36265467
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrates as a source of energy.
Jéquier E
Am J Clin Nutr; 1994 Mar; 59(3 Suppl):682S-685S. PubMed ID: 8116550
[TBL] [Abstract][Full Text] [Related]
5. Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer.
Keathley R; Kocherginsky M; Davuluri R; Matei D
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509311
[TBL] [Abstract][Full Text] [Related]
6. Progress in molecular feature of smoldering mantle cell lymphoma.
Jiang P; Desai A; Ye H
Exp Hematol Oncol; 2021 Jul; 10(1):41. PubMed ID: 34256839
[TBL] [Abstract][Full Text] [Related]
7. The pan-cancer landscape of prognostic germline variants in 10,582 patients.
Chatrath A; Przanowska R; Kiran S; Su Z; Saha S; Wilson B; Tsunematsu T; Ahn JH; Lee KY; Paulsen T; Sobierajska E; Kiran M; Tang X; Li T; Kumar P; Ratan A; Dutta A
Genome Med; 2020 Feb; 12(1):15. PubMed ID: 32066500
[TBL] [Abstract][Full Text] [Related]
8. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
9. Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
Rozovski U; Keating MJ; Estrov Z
Acta Haematol; 2018; 140(1):51-54. PubMed ID: 30114695
[TBL] [Abstract][Full Text] [Related]
10. A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients.
Li X; Wu N; Li B
Medicine (Baltimore); 2019 May; 98(22):e15811. PubMed ID: 31145313
[TBL] [Abstract][Full Text] [Related]
11. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
Walsh SH; Thorsélius M; Johnson A; Söderberg O; Jerkeman M; Björck E; Eriksson I; Thunberg U; Landgren O; Ehinger M; Löfvenberg E; Wallman K; Enblad G; Sander B; Porwit-MacDonald A; Dictor M; Olofsson T; Sundström C; Roos G; Rosenquist R
Blood; 2003 May; 101(10):4047-54. PubMed ID: 12637326
[TBL] [Abstract][Full Text] [Related]
12. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Jain P; Nogueras González GM; Kanagal-Shamanna R; Rozovski U; Sarwari N; Tam C; Wierda WG; Thompson PA; Jain N; Luthra R; Quesada A; Sanchez-Petitto G; Ferrajoli A; Burger J; Kantarjian H; Cortes J; O'Brien S; Keating MJ; Estrov Z
Br J Haematol; 2018 Jan; 180(1):33-40. PubMed ID: 29164608
[TBL] [Abstract][Full Text] [Related]
13. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Visentin A; Facco M; Gurrieri C; Pagnin E; Martini V; Imbergamo S; Frezzato F; Trimarco V; Severin F; Raggi F; Scomazzon E; Pravato S; Piazza F; Semenzato G; Trentin L
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):678-685.e4. PubMed ID: 31371221
[TBL] [Abstract][Full Text] [Related]
15. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
